Global AI Pharma Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global AI Pharma market size was valued at US$ million in 2023. With growing demand in downstream market, the AI Pharma is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global AI Pharma market. AI Pharma are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of AI Pharma. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the AI Pharma market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on AI Pharma market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the AI Pharma market. It may include historical data, market segmentation by Type (e.g., Self-developed Oipeline, Contract Research Organization (CRO)), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the AI Pharma market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the AI Pharma market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the AI Pharma industry. This include advancements in AI Pharma technology, AI Pharma new entrants, AI Pharma new investment, and other innovations that are shaping the future of AI Pharma.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the AI Pharma market. It includes factors influencing customer ' purchasing decisions, preferences for AI Pharma product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the AI Pharma market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting AI Pharma market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the AI Pharma market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the AI Pharma industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the AI Pharma market.
Market Segmentation:
AI Pharma market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Self-developed Oipeline
Contract Research Organization (CRO)
Other
Segmentation by application
Preclinical Stage (Optimization of Lead Compounds, etc.)
Clinical Trial Phase (Predicting Treatment Outcome, etc.)
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Recursion
Insilico Medicine
Exscientia
BenevolentAI
Atomwise
Roivant Sciences
Schrцdinger
Lantern Pharma
XtalPi
Landos Biopharma
Relay Therapeutics
Accutar Biotech
Deep Genomics
Oncocross
AI Therapeutics
BioMap
METiS Pharmaceuticals
NeoX Biotech
StoneWise
Deep Intelligent Pharma
Gigaceuticals
Chemical.AI
Artivila
Galixir
Xbiome
According to our LPI (LP Information) latest study, the global AI Pharma market size was valued at US$ million in 2023. With growing demand in downstream market, the AI Pharma is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global AI Pharma market. AI Pharma are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of AI Pharma. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the AI Pharma market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on AI Pharma market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the AI Pharma market. It may include historical data, market segmentation by Type (e.g., Self-developed Oipeline, Contract Research Organization (CRO)), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the AI Pharma market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the AI Pharma market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the AI Pharma industry. This include advancements in AI Pharma technology, AI Pharma new entrants, AI Pharma new investment, and other innovations that are shaping the future of AI Pharma.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the AI Pharma market. It includes factors influencing customer ' purchasing decisions, preferences for AI Pharma product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the AI Pharma market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting AI Pharma market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the AI Pharma market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the AI Pharma industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the AI Pharma market.
Market Segmentation:
AI Pharma market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Self-developed Oipeline
Contract Research Organization (CRO)
Other
Segmentation by application
Preclinical Stage (Optimization of Lead Compounds, etc.)
Clinical Trial Phase (Predicting Treatment Outcome, etc.)
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Recursion
Insilico Medicine
Exscientia
BenevolentAI
Atomwise
Roivant Sciences
Schrцdinger
Lantern Pharma
XtalPi
Landos Biopharma
Relay Therapeutics
Accutar Biotech
Deep Genomics
Oncocross
AI Therapeutics
BioMap
METiS Pharmaceuticals
NeoX Biotech
StoneWise
Deep Intelligent Pharma
Gigaceuticals
Chemical.AI
Artivila
Galixir
Xbiome
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global AI Pharma Market Size 2019-2030
2.1.2 AI Pharma Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 AI Pharma Segment by Type
2.2.1 Self-developed Oipeline
2.2.2 Contract Research Organization (CRO)
2.2.3 Other
2.3 AI Pharma Market Size by Type
2.3.1 AI Pharma Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global AI Pharma Market Size Market Share by Type (2019-2024)
2.4 AI Pharma Segment by Application
2.4.1 Preclinical Stage (Optimization of Lead Compounds, etc.)
2.4.2 Clinical Trial Phase (Predicting Treatment Outcome, etc.)
2.5 AI Pharma Market Size by Application
2.5.1 AI Pharma Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global AI Pharma Market Size Market Share by Application (2019-2024)
3 AI PHARMA MARKET SIZE BY PLAYER
3.1 AI Pharma Market Size Market Share by Players
3.1.1 Global AI Pharma Revenue by Players (2019-2024)
3.1.2 Global AI Pharma Revenue Market Share by Players (2019-2024)
3.2 Global AI Pharma Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AI PHARMA BY REGIONS
4.1 AI Pharma Market Size by Regions (2019-2024)
4.2 Americas AI Pharma Market Size Growth (2019-2024)
4.3 APAC AI Pharma Market Size Growth (2019-2024)
4.4 Europe AI Pharma Market Size Growth (2019-2024)
4.5 Middle East & Africa AI Pharma Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas AI Pharma Market Size by Country (2019-2024)
5.2 Americas AI Pharma Market Size by Type (2019-2024)
5.3 Americas AI Pharma Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC AI Pharma Market Size by Region (2019-2024)
6.2 APAC AI Pharma Market Size by Type (2019-2024)
6.3 APAC AI Pharma Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe AI Pharma by Country (2019-2024)
7.2 Europe AI Pharma Market Size by Type (2019-2024)
7.3 Europe AI Pharma Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa AI Pharma by Region (2019-2024)
8.2 Middle East & Africa AI Pharma Market Size by Type (2019-2024)
8.3 Middle East & Africa AI Pharma Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL AI PHARMA MARKET FORECAST
10.1 Global AI Pharma Forecast by Regions (2025-2030)
10.1.1 Global AI Pharma Forecast by Regions (2025-2030)
10.1.2 Americas AI Pharma Forecast
10.1.3 APAC AI Pharma Forecast
10.1.4 Europe AI Pharma Forecast
10.1.5 Middle East & Africa AI Pharma Forecast
10.2 Americas AI Pharma Forecast by Country (2025-2030)
10.2.1 United States AI Pharma Market Forecast
10.2.2 Canada AI Pharma Market Forecast
10.2.3 Mexico AI Pharma Market Forecast
10.2.4 Brazil AI Pharma Market Forecast
10.3 APAC AI Pharma Forecast by Region (2025-2030)
10.3.1 China AI Pharma Market Forecast
10.3.2 Japan AI Pharma Market Forecast
10.3.3 Korea AI Pharma Market Forecast
10.3.4 Southeast Asia AI Pharma Market Forecast
10.3.5 India AI Pharma Market Forecast
10.3.6 Australia AI Pharma Market Forecast
10.4 Europe AI Pharma Forecast by Country (2025-2030)
10.4.1 Germany AI Pharma Market Forecast
10.4.2 France AI Pharma Market Forecast
10.4.3 UK AI Pharma Market Forecast
10.4.4 Italy AI Pharma Market Forecast
10.4.5 Russia AI Pharma Market Forecast
10.5 Middle East & Africa AI Pharma Forecast by Region (2025-2030)
10.5.1 Egypt AI Pharma Market Forecast
10.5.2 South Africa AI Pharma Market Forecast
10.5.3 Israel AI Pharma Market Forecast
10.5.4 Turkey AI Pharma Market Forecast
10.5.5 GCC Countries AI Pharma Market Forecast
10.6 Global AI Pharma Forecast by Type (2025-2030)
10.7 Global AI Pharma Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Recursion
11.1.1 Recursion Company Information
11.1.2 Recursion AI Pharma Product Offered
11.1.3 Recursion AI Pharma Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Recursion Main Business Overview
11.1.5 Recursion Latest Developments
11.2 Insilico Medicine
11.2.1 Insilico Medicine Company Information
11.2.2 Insilico Medicine AI Pharma Product Offered
11.2.3 Insilico Medicine AI Pharma Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Insilico Medicine Main Business Overview
11.2.5 Insilico Medicine Latest Developments
11.3 Exscientia
11.3.1 Exscientia Company Information
11.3.2 Exscientia AI Pharma Product Offered
11.3.3 Exscientia AI Pharma Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Exscientia Main Business Overview
11.3.5 Exscientia Latest Developments
11.4 BenevolentAI
11.4.1 BenevolentAI Company Information
11.4.2 BenevolentAI AI Pharma Product Offered
11.4.3 BenevolentAI AI Pharma Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 BenevolentAI Main Business Overview
11.4.5 BenevolentAI Latest Developments
11.5 Atomwise
11.5.1 Atomwise Company Information
11.5.2 Atomwise AI Pharma Product Offered
11.5.3 Atomwise AI Pharma Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Atomwise Main Business Overview
11.5.5 Atomwise Latest Developments
11.6 Roivant Sciences
11.6.1 Roivant Sciences Company Information
11.6.2 Roivant Sciences AI Pharma Product Offered
11.6.3 Roivant Sciences AI Pharma Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Roivant Sciences Main Business Overview
11.6.5 Roivant Sciences Latest Developments
11.7 Schrцdinger
11.7.1 Schrцdinger Company Information
11.7.2 Schrцdinger AI Pharma Product Offered
11.7.3 Schrцdinger AI Pharma Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Schrцdinger Main Business Overview
11.7.5 Schrцdinger Latest Developments
11.8 Lantern Pharma
11.8.1 Lantern Pharma Company Information
11.8.2 Lantern Pharma AI Pharma Product Offered
11.8.3 Lantern Pharma AI Pharma Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Lantern Pharma Main Business Overview
11.8.5 Lantern Pharma Latest Developments
11.9 XtalPi
11.9.1 XtalPi Company Information
11.9.2 XtalPi AI Pharma Product Offered
11.9.3 XtalPi AI Pharma Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 XtalPi Main Business Overview
11.9.5 XtalPi Latest Developments
11.10 Landos Biopharma
11.10.1 Landos Biopharma Company Information
11.10.2 Landos Biopharma AI Pharma Product Offered
11.10.3 Landos Biopharma AI Pharma Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Landos Biopharma Main Business Overview
11.10.5 Landos Biopharma Latest Developments
11.11 Relay Therapeutics
11.11.1 Relay Therapeutics Company Information
11.11.2 Relay Therapeutics AI Pharma Product Offered
11.11.3 Relay Therapeutics AI Pharma Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Relay Therapeutics Main Business Overview
11.11.5 Relay Therapeutics Latest Developments
11.12 Accutar Biotech
11.12.1 Accutar Biotech Company Information
11.12.2 Accutar Biotech AI Pharma Product Offered
11.12.3 Accutar Biotech AI Pharma Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Accutar Biotech Main Business Overview
11.12.5 Accutar Biotech Latest Developments
11.13 Deep Genomics
11.13.1 Deep Genomics Company Information
11.13.2 Deep Genomics AI Pharma Product Offered
11.13.3 Deep Genomics AI Pharma Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Deep Genomics Main Business Overview
11.13.5 Deep Genomics Latest Developments
11.14 Oncocross
11.14.1 Oncocross Company Information
11.14.2 Oncocross AI Pharma Product Offered
11.14.3 Oncocross AI Pharma Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Oncocross Main Business Overview
11.14.5 Oncocross Latest Developments
11.15 AI Therapeutics
11.15.1 AI Therapeutics Company Information
11.15.2 AI Therapeutics AI Pharma Product Offered
11.15.3 AI Therapeutics AI Pharma Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 AI Therapeutics Main Business Overview
11.15.5 AI Therapeutics Latest Developments
11.16 BioMap
11.16.1 BioMap Company Information
11.16.2 BioMap AI Pharma Product Offered
11.16.3 BioMap AI Pharma Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 BioMap Main Business Overview
11.16.5 BioMap Latest Developments
11.17 METiS Pharmaceuticals
11.17.1 METiS Pharmaceuticals Company Information
11.17.2 METiS Pharmaceuticals AI Pharma Product Offered
11.17.3 METiS Pharmaceuticals AI Pharma Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 METiS Pharmaceuticals Main Business Overview
11.17.5 METiS Pharmaceuticals Latest Developments
11.18 NeoX Biotech
11.18.1 NeoX Biotech Company Information
11.18.2 NeoX Biotech AI Pharma Product Offered
11.18.3 NeoX Biotech AI Pharma Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 NeoX Biotech Main Business Overview
11.18.5 NeoX Biotech Latest Developments
11.19 StoneWise
11.19.1 StoneWise Company Information
11.19.2 StoneWise AI Pharma Product Offered
11.19.3 StoneWise AI Pharma Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 StoneWise Main Business Overview
11.19.5 StoneWise Latest Developments
11.20 Deep Intelligent Pharma
11.20.1 Deep Intelligent Pharma Company Information
11.20.2 Deep Intelligent Pharma AI Pharma Product Offered
11.20.3 Deep Intelligent Pharma AI Pharma Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Deep Intelligent Pharma Main Business Overview
11.20.5 Deep Intelligent Pharma Latest Developments
11.21 Gigaceuticals
11.21.1 Gigaceuticals Company Information
11.21.2 Gigaceuticals AI Pharma Product Offered
11.21.3 Gigaceuticals AI Pharma Revenue, Gross Margin and Market Share (2019-2024)
11.21.4 Gigaceuticals Main Business Overview
11.21.5 Gigaceuticals Latest Developments
11.22 Chemical.AI
11.22.1 Chemical.AI Company Information
11.22.2 Chemical.AI AI Pharma Product Offered
11.22.3 Chemical.AI AI Pharma Revenue, Gross Margin and Market Share (2019-2024)
11.22.4 Chemical.AI Main Business Overview
11.22.5 Chemical.AI Latest Developments
11.23 Artivila
11.23.1 Artivila Company Information
11.23.2 Artivila AI Pharma Product Offered
11.23.3 Artivila AI Pharma Revenue, Gross Margin and Market Share (2019-2024)
11.23.4 Artivila Main Business Overview
11.23.5 Artivila Latest Developments
11.24 Galixir
11.24.1 Galixir Company Information
11.24.2 Galixir AI Pharma Product Offered
11.24.3 Galixir AI Pharma Revenue, Gross Margin and Market Share (2019-2024)
11.24.4 Galixir Main Business Overview
11.24.5 Galixir Latest Developments
11.25 Xbiome
11.25.1 Xbiome Company Information
11.25.2 Xbiome AI Pharma Product Offered
11.25.3 Xbiome AI Pharma Revenue, Gross Margin and Market Share (2019-2024)
11.25.4 Xbiome Main Business Overview
11.25.5 Xbiome Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global AI Pharma Market Size 2019-2030
2.1.2 AI Pharma Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 AI Pharma Segment by Type
2.2.1 Self-developed Oipeline
2.2.2 Contract Research Organization (CRO)
2.2.3 Other
2.3 AI Pharma Market Size by Type
2.3.1 AI Pharma Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global AI Pharma Market Size Market Share by Type (2019-2024)
2.4 AI Pharma Segment by Application
2.4.1 Preclinical Stage (Optimization of Lead Compounds, etc.)
2.4.2 Clinical Trial Phase (Predicting Treatment Outcome, etc.)
2.5 AI Pharma Market Size by Application
2.5.1 AI Pharma Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global AI Pharma Market Size Market Share by Application (2019-2024)
3 AI PHARMA MARKET SIZE BY PLAYER
3.1 AI Pharma Market Size Market Share by Players
3.1.1 Global AI Pharma Revenue by Players (2019-2024)
3.1.2 Global AI Pharma Revenue Market Share by Players (2019-2024)
3.2 Global AI Pharma Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AI PHARMA BY REGIONS
4.1 AI Pharma Market Size by Regions (2019-2024)
4.2 Americas AI Pharma Market Size Growth (2019-2024)
4.3 APAC AI Pharma Market Size Growth (2019-2024)
4.4 Europe AI Pharma Market Size Growth (2019-2024)
4.5 Middle East & Africa AI Pharma Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas AI Pharma Market Size by Country (2019-2024)
5.2 Americas AI Pharma Market Size by Type (2019-2024)
5.3 Americas AI Pharma Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC AI Pharma Market Size by Region (2019-2024)
6.2 APAC AI Pharma Market Size by Type (2019-2024)
6.3 APAC AI Pharma Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe AI Pharma by Country (2019-2024)
7.2 Europe AI Pharma Market Size by Type (2019-2024)
7.3 Europe AI Pharma Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa AI Pharma by Region (2019-2024)
8.2 Middle East & Africa AI Pharma Market Size by Type (2019-2024)
8.3 Middle East & Africa AI Pharma Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL AI PHARMA MARKET FORECAST
10.1 Global AI Pharma Forecast by Regions (2025-2030)
10.1.1 Global AI Pharma Forecast by Regions (2025-2030)
10.1.2 Americas AI Pharma Forecast
10.1.3 APAC AI Pharma Forecast
10.1.4 Europe AI Pharma Forecast
10.1.5 Middle East & Africa AI Pharma Forecast
10.2 Americas AI Pharma Forecast by Country (2025-2030)
10.2.1 United States AI Pharma Market Forecast
10.2.2 Canada AI Pharma Market Forecast
10.2.3 Mexico AI Pharma Market Forecast
10.2.4 Brazil AI Pharma Market Forecast
10.3 APAC AI Pharma Forecast by Region (2025-2030)
10.3.1 China AI Pharma Market Forecast
10.3.2 Japan AI Pharma Market Forecast
10.3.3 Korea AI Pharma Market Forecast
10.3.4 Southeast Asia AI Pharma Market Forecast
10.3.5 India AI Pharma Market Forecast
10.3.6 Australia AI Pharma Market Forecast
10.4 Europe AI Pharma Forecast by Country (2025-2030)
10.4.1 Germany AI Pharma Market Forecast
10.4.2 France AI Pharma Market Forecast
10.4.3 UK AI Pharma Market Forecast
10.4.4 Italy AI Pharma Market Forecast
10.4.5 Russia AI Pharma Market Forecast
10.5 Middle East & Africa AI Pharma Forecast by Region (2025-2030)
10.5.1 Egypt AI Pharma Market Forecast
10.5.2 South Africa AI Pharma Market Forecast
10.5.3 Israel AI Pharma Market Forecast
10.5.4 Turkey AI Pharma Market Forecast
10.5.5 GCC Countries AI Pharma Market Forecast
10.6 Global AI Pharma Forecast by Type (2025-2030)
10.7 Global AI Pharma Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Recursion
11.1.1 Recursion Company Information
11.1.2 Recursion AI Pharma Product Offered
11.1.3 Recursion AI Pharma Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Recursion Main Business Overview
11.1.5 Recursion Latest Developments
11.2 Insilico Medicine
11.2.1 Insilico Medicine Company Information
11.2.2 Insilico Medicine AI Pharma Product Offered
11.2.3 Insilico Medicine AI Pharma Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Insilico Medicine Main Business Overview
11.2.5 Insilico Medicine Latest Developments
11.3 Exscientia
11.3.1 Exscientia Company Information
11.3.2 Exscientia AI Pharma Product Offered
11.3.3 Exscientia AI Pharma Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Exscientia Main Business Overview
11.3.5 Exscientia Latest Developments
11.4 BenevolentAI
11.4.1 BenevolentAI Company Information
11.4.2 BenevolentAI AI Pharma Product Offered
11.4.3 BenevolentAI AI Pharma Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 BenevolentAI Main Business Overview
11.4.5 BenevolentAI Latest Developments
11.5 Atomwise
11.5.1 Atomwise Company Information
11.5.2 Atomwise AI Pharma Product Offered
11.5.3 Atomwise AI Pharma Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Atomwise Main Business Overview
11.5.5 Atomwise Latest Developments
11.6 Roivant Sciences
11.6.1 Roivant Sciences Company Information
11.6.2 Roivant Sciences AI Pharma Product Offered
11.6.3 Roivant Sciences AI Pharma Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Roivant Sciences Main Business Overview
11.6.5 Roivant Sciences Latest Developments
11.7 Schrцdinger
11.7.1 Schrцdinger Company Information
11.7.2 Schrцdinger AI Pharma Product Offered
11.7.3 Schrцdinger AI Pharma Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Schrцdinger Main Business Overview
11.7.5 Schrцdinger Latest Developments
11.8 Lantern Pharma
11.8.1 Lantern Pharma Company Information
11.8.2 Lantern Pharma AI Pharma Product Offered
11.8.3 Lantern Pharma AI Pharma Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Lantern Pharma Main Business Overview
11.8.5 Lantern Pharma Latest Developments
11.9 XtalPi
11.9.1 XtalPi Company Information
11.9.2 XtalPi AI Pharma Product Offered
11.9.3 XtalPi AI Pharma Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 XtalPi Main Business Overview
11.9.5 XtalPi Latest Developments
11.10 Landos Biopharma
11.10.1 Landos Biopharma Company Information
11.10.2 Landos Biopharma AI Pharma Product Offered
11.10.3 Landos Biopharma AI Pharma Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Landos Biopharma Main Business Overview
11.10.5 Landos Biopharma Latest Developments
11.11 Relay Therapeutics
11.11.1 Relay Therapeutics Company Information
11.11.2 Relay Therapeutics AI Pharma Product Offered
11.11.3 Relay Therapeutics AI Pharma Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Relay Therapeutics Main Business Overview
11.11.5 Relay Therapeutics Latest Developments
11.12 Accutar Biotech
11.12.1 Accutar Biotech Company Information
11.12.2 Accutar Biotech AI Pharma Product Offered
11.12.3 Accutar Biotech AI Pharma Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Accutar Biotech Main Business Overview
11.12.5 Accutar Biotech Latest Developments
11.13 Deep Genomics
11.13.1 Deep Genomics Company Information
11.13.2 Deep Genomics AI Pharma Product Offered
11.13.3 Deep Genomics AI Pharma Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Deep Genomics Main Business Overview
11.13.5 Deep Genomics Latest Developments
11.14 Oncocross
11.14.1 Oncocross Company Information
11.14.2 Oncocross AI Pharma Product Offered
11.14.3 Oncocross AI Pharma Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Oncocross Main Business Overview
11.14.5 Oncocross Latest Developments
11.15 AI Therapeutics
11.15.1 AI Therapeutics Company Information
11.15.2 AI Therapeutics AI Pharma Product Offered
11.15.3 AI Therapeutics AI Pharma Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 AI Therapeutics Main Business Overview
11.15.5 AI Therapeutics Latest Developments
11.16 BioMap
11.16.1 BioMap Company Information
11.16.2 BioMap AI Pharma Product Offered
11.16.3 BioMap AI Pharma Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 BioMap Main Business Overview
11.16.5 BioMap Latest Developments
11.17 METiS Pharmaceuticals
11.17.1 METiS Pharmaceuticals Company Information
11.17.2 METiS Pharmaceuticals AI Pharma Product Offered
11.17.3 METiS Pharmaceuticals AI Pharma Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 METiS Pharmaceuticals Main Business Overview
11.17.5 METiS Pharmaceuticals Latest Developments
11.18 NeoX Biotech
11.18.1 NeoX Biotech Company Information
11.18.2 NeoX Biotech AI Pharma Product Offered
11.18.3 NeoX Biotech AI Pharma Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 NeoX Biotech Main Business Overview
11.18.5 NeoX Biotech Latest Developments
11.19 StoneWise
11.19.1 StoneWise Company Information
11.19.2 StoneWise AI Pharma Product Offered
11.19.3 StoneWise AI Pharma Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 StoneWise Main Business Overview
11.19.5 StoneWise Latest Developments
11.20 Deep Intelligent Pharma
11.20.1 Deep Intelligent Pharma Company Information
11.20.2 Deep Intelligent Pharma AI Pharma Product Offered
11.20.3 Deep Intelligent Pharma AI Pharma Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Deep Intelligent Pharma Main Business Overview
11.20.5 Deep Intelligent Pharma Latest Developments
11.21 Gigaceuticals
11.21.1 Gigaceuticals Company Information
11.21.2 Gigaceuticals AI Pharma Product Offered
11.21.3 Gigaceuticals AI Pharma Revenue, Gross Margin and Market Share (2019-2024)
11.21.4 Gigaceuticals Main Business Overview
11.21.5 Gigaceuticals Latest Developments
11.22 Chemical.AI
11.22.1 Chemical.AI Company Information
11.22.2 Chemical.AI AI Pharma Product Offered
11.22.3 Chemical.AI AI Pharma Revenue, Gross Margin and Market Share (2019-2024)
11.22.4 Chemical.AI Main Business Overview
11.22.5 Chemical.AI Latest Developments
11.23 Artivila
11.23.1 Artivila Company Information
11.23.2 Artivila AI Pharma Product Offered
11.23.3 Artivila AI Pharma Revenue, Gross Margin and Market Share (2019-2024)
11.23.4 Artivila Main Business Overview
11.23.5 Artivila Latest Developments
11.24 Galixir
11.24.1 Galixir Company Information
11.24.2 Galixir AI Pharma Product Offered
11.24.3 Galixir AI Pharma Revenue, Gross Margin and Market Share (2019-2024)
11.24.4 Galixir Main Business Overview
11.24.5 Galixir Latest Developments
11.25 Xbiome
11.25.1 Xbiome Company Information
11.25.2 Xbiome AI Pharma Product Offered
11.25.3 Xbiome AI Pharma Revenue, Gross Margin and Market Share (2019-2024)
11.25.4 Xbiome Main Business Overview
11.25.5 Xbiome Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. AI Pharma Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Self-developed Oipeline
Table 3. Major Players of Contract Research Organization (CRO)
Table 4. Major Players of Other
Table 5. AI Pharma Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global AI Pharma Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global AI Pharma Market Size Market Share by Type (2019-2024)
Table 8. AI Pharma Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global AI Pharma Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global AI Pharma Market Size Market Share by Application (2019-2024)
Table 11. Global AI Pharma Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global AI Pharma Revenue Market Share by Player (2019-2024)
Table 13. AI Pharma Key Players Head office and Products Offered
Table 14. AI Pharma Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global AI Pharma Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global AI Pharma Market Size Market Share by Regions (2019-2024)
Table 19. Global AI Pharma Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global AI Pharma Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas AI Pharma Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas AI Pharma Market Size Market Share by Country (2019-2024)
Table 23. Americas AI Pharma Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas AI Pharma Market Size Market Share by Type (2019-2024)
Table 25. Americas AI Pharma Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas AI Pharma Market Size Market Share by Application (2019-2024)
Table 27. APAC AI Pharma Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC AI Pharma Market Size Market Share by Region (2019-2024)
Table 29. APAC AI Pharma Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC AI Pharma Market Size Market Share by Type (2019-2024)
Table 31. APAC AI Pharma Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC AI Pharma Market Size Market Share by Application (2019-2024)
Table 33. Europe AI Pharma Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe AI Pharma Market Size Market Share by Country (2019-2024)
Table 35. Europe AI Pharma Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe AI Pharma Market Size Market Share by Type (2019-2024)
Table 37. Europe AI Pharma Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe AI Pharma Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa AI Pharma Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa AI Pharma Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa AI Pharma Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa AI Pharma Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa AI Pharma Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa AI Pharma Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of AI Pharma
Table 46. Key Market Challenges & Risks of AI Pharma
Table 47. Key Industry Trends of AI Pharma
Table 48. Global AI Pharma Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global AI Pharma Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global AI Pharma Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global AI Pharma Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Recursion Details, Company Type, AI Pharma Area Served and Its Competitors
Table 53. Recursion AI Pharma Product Offered
Table 54. Recursion AI Pharma Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Recursion Main Business
Table 56. Recursion Latest Developments
Table 57. Insilico Medicine Details, Company Type, AI Pharma Area Served and Its Competitors
Table 58. Insilico Medicine AI Pharma Product Offered
Table 59. Insilico Medicine Main Business
Table 60. Insilico Medicine AI Pharma Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Insilico Medicine Latest Developments
Table 62. Exscientia Details, Company Type, AI Pharma Area Served and Its Competitors
Table 63. Exscientia AI Pharma Product Offered
Table 64. Exscientia Main Business
Table 65. Exscientia AI Pharma Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Exscientia Latest Developments
Table 67. BenevolentAI Details, Company Type, AI Pharma Area Served and Its Competitors
Table 68. BenevolentAI AI Pharma Product Offered
Table 69. BenevolentAI Main Business
Table 70. BenevolentAI AI Pharma Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. BenevolentAI Latest Developments
Table 72. Atomwise Details, Company Type, AI Pharma Area Served and Its Competitors
Table 73. Atomwise AI Pharma Product Offered
Table 74. Atomwise Main Business
Table 75. Atomwise AI Pharma Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Atomwise Latest Developments
Table 77. Roivant Sciences Details, Company Type, AI Pharma Area Served and Its Competitors
Table 78. Roivant Sciences AI Pharma Product Offered
Table 79. Roivant Sciences Main Business
Table 80. Roivant Sciences AI Pharma Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Roivant Sciences Latest Developments
Table 82. Schrцdinger Details, Company Type, AI Pharma Area Served and Its Competitors
Table 83. Schrцdinger AI Pharma Product Offered
Table 84. Schrцdinger Main Business
Table 85. Schrцdinger AI Pharma Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Schrцdinger Latest Developments
Table 87. Lantern Pharma Details, Company Type, AI Pharma Area Served and Its Competitors
Table 88. Lantern Pharma AI Pharma Product Offered
Table 89. Lantern Pharma Main Business
Table 90. Lantern Pharma AI Pharma Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Lantern Pharma Latest Developments
Table 92. XtalPi Details, Company Type, AI Pharma Area Served and Its Competitors
Table 93. XtalPi AI Pharma Product Offered
Table 94. XtalPi Main Business
Table 95. XtalPi AI Pharma Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. XtalPi Latest Developments
Table 97. Landos Biopharma Details, Company Type, AI Pharma Area Served and Its Competitors
Table 98. Landos Biopharma AI Pharma Product Offered
Table 99. Landos Biopharma Main Business
Table 100. Landos Biopharma AI Pharma Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. Landos Biopharma Latest Developments
Table 102. Relay Therapeutics Details, Company Type, AI Pharma Area Served and Its Competitors
Table 103. Relay Therapeutics AI Pharma Product Offered
Table 104. Relay Therapeutics AI Pharma Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. Relay Therapeutics Main Business
Table 106. Relay Therapeutics Latest Developments
Table 107. Accutar Biotech Details, Company Type, AI Pharma Area Served and Its Competitors
Table 108. Accutar Biotech AI Pharma Product Offered
Table 109. Accutar Biotech Main Business
Table 110. Accutar Biotech AI Pharma Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 111. Accutar Biotech Latest Developments
Table 112. Deep Genomics Details, Company Type, AI Pharma Area Served and Its Competitors
Table 113. Deep Genomics AI Pharma Product Offered
Table 114. Deep Genomics Main Business
Table 115. Deep Genomics AI Pharma Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 116. Deep Genomics Latest Developments
Table 117. Oncocross Details, Company Type, AI Pharma Area Served and Its Competitors
Table 118. Oncocross AI Pharma Product Offered
Table 119. Oncocross Main Business
Table 120. Oncocross AI Pharma Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 121. Oncocross Latest Developments
Table 122. AI Therapeutics Details, Company Type, AI Pharma Area Served and Its Competitors
Table 123. AI Therapeutics AI Pharma Product Offered
Table 124. AI Therapeutics Main Business
Table 125. AI Therapeutics AI Pharma Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 126. AI Therapeutics Latest Developments
Table 127. BioMap Details, Company Type, AI Pharma Area Served and Its Competitors
Table 128. BioMap AI Pharma Product Offered
Table 129. BioMap Main Business
Table 130. BioMap AI Pharma Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 131. BioMap Latest Developments
Table 132. METiS Pharmaceuticals Details, Company Type, AI Pharma Area Served and Its Competitors
Table 133. METiS Pharmaceuticals AI Pharma Product Offered
Table 134. METiS Pharmaceuticals Main Business
Table 135. METiS Pharmaceuticals AI Pharma Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 136. METiS Pharmaceuticals Latest Developments
Table 137. NeoX Biotech Details, Company Type, AI Pharma Area Served and Its Competitors
Table 138. NeoX Biotech AI Pharma Product Offered
Table 139. NeoX Biotech Main Business
Table 140. NeoX Biotech AI Pharma Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 141. NeoX Biotech Latest Developments
Table 142. StoneWise Details, Company Type, AI Pharma Area Served and Its Competitors
Table 143. StoneWise AI Pharma Product Offered
Table 144. StoneWise Main Business
Table 145. StoneWise AI Pharma Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 146. StoneWise Latest Developments
Table 147. Deep Intelligent Pharma Details, Company Type, AI Pharma Area Served and Its Competitors
Table 148. Deep Intelligent Pharma AI Pharma Product Offered
Table 149. Deep Intelligent Pharma Main Business
Table 150. Deep Intelligent Pharma AI Pharma Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 151. Deep Intelligent Pharma Latest Developments
Table 152. Gigaceuticals Details, Company Type, AI Pharma Area Served and Its Competitors
Table 153. Gigaceuticals AI Pharma Product Offered
Table 154. Gigaceuticals AI Pharma Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 155. Gigaceuticals Main Business
Table 156. Gigaceuticals Latest Developments
Table 157. Chemical.AI Details, Company Type, AI Pharma Area Served and Its Competitors
Table 158. Chemical.AI AI Pharma Product Offered
Table 159. Chemical.AI Main Business
Table 160. Chemical.AI AI Pharma Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 161. Chemical.AI Latest Developments
Table 162. Artivila Details, Company Type, AI Pharma Area Served and Its Competitors
Table 163. Artivila AI Pharma Product Offered
Table 164. Artivila Main Business
Table 165. Artivila AI Pharma Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 166. Artivila Latest Developments
Table 167. Galixir Details, Company Type, AI Pharma Area Served and Its Competitors
Table 168. Galixir AI Pharma Product Offered
Table 169. Galixir Main Business
Table 170. Galixir AI Pharma Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 171. Galixir Latest Developments
Table 172. Xbiome Details, Company Type, AI Pharma Area Served and Its Competitors
Table 173. Xbiome AI Pharma Product Offered
Table 174. Xbiome Main Business
Table 175. Xbiome AI Pharma Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 176. Xbiome Latest Developments
Table 1. AI Pharma Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Self-developed Oipeline
Table 3. Major Players of Contract Research Organization (CRO)
Table 4. Major Players of Other
Table 5. AI Pharma Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global AI Pharma Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global AI Pharma Market Size Market Share by Type (2019-2024)
Table 8. AI Pharma Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global AI Pharma Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global AI Pharma Market Size Market Share by Application (2019-2024)
Table 11. Global AI Pharma Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global AI Pharma Revenue Market Share by Player (2019-2024)
Table 13. AI Pharma Key Players Head office and Products Offered
Table 14. AI Pharma Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global AI Pharma Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global AI Pharma Market Size Market Share by Regions (2019-2024)
Table 19. Global AI Pharma Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global AI Pharma Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas AI Pharma Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas AI Pharma Market Size Market Share by Country (2019-2024)
Table 23. Americas AI Pharma Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas AI Pharma Market Size Market Share by Type (2019-2024)
Table 25. Americas AI Pharma Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas AI Pharma Market Size Market Share by Application (2019-2024)
Table 27. APAC AI Pharma Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC AI Pharma Market Size Market Share by Region (2019-2024)
Table 29. APAC AI Pharma Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC AI Pharma Market Size Market Share by Type (2019-2024)
Table 31. APAC AI Pharma Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC AI Pharma Market Size Market Share by Application (2019-2024)
Table 33. Europe AI Pharma Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe AI Pharma Market Size Market Share by Country (2019-2024)
Table 35. Europe AI Pharma Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe AI Pharma Market Size Market Share by Type (2019-2024)
Table 37. Europe AI Pharma Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe AI Pharma Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa AI Pharma Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa AI Pharma Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa AI Pharma Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa AI Pharma Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa AI Pharma Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa AI Pharma Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of AI Pharma
Table 46. Key Market Challenges & Risks of AI Pharma
Table 47. Key Industry Trends of AI Pharma
Table 48. Global AI Pharma Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global AI Pharma Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global AI Pharma Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global AI Pharma Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Recursion Details, Company Type, AI Pharma Area Served and Its Competitors
Table 53. Recursion AI Pharma Product Offered
Table 54. Recursion AI Pharma Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Recursion Main Business
Table 56. Recursion Latest Developments
Table 57. Insilico Medicine Details, Company Type, AI Pharma Area Served and Its Competitors
Table 58. Insilico Medicine AI Pharma Product Offered
Table 59. Insilico Medicine Main Business
Table 60. Insilico Medicine AI Pharma Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Insilico Medicine Latest Developments
Table 62. Exscientia Details, Company Type, AI Pharma Area Served and Its Competitors
Table 63. Exscientia AI Pharma Product Offered
Table 64. Exscientia Main Business
Table 65. Exscientia AI Pharma Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Exscientia Latest Developments
Table 67. BenevolentAI Details, Company Type, AI Pharma Area Served and Its Competitors
Table 68. BenevolentAI AI Pharma Product Offered
Table 69. BenevolentAI Main Business
Table 70. BenevolentAI AI Pharma Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. BenevolentAI Latest Developments
Table 72. Atomwise Details, Company Type, AI Pharma Area Served and Its Competitors
Table 73. Atomwise AI Pharma Product Offered
Table 74. Atomwise Main Business
Table 75. Atomwise AI Pharma Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Atomwise Latest Developments
Table 77. Roivant Sciences Details, Company Type, AI Pharma Area Served and Its Competitors
Table 78. Roivant Sciences AI Pharma Product Offered
Table 79. Roivant Sciences Main Business
Table 80. Roivant Sciences AI Pharma Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Roivant Sciences Latest Developments
Table 82. Schrцdinger Details, Company Type, AI Pharma Area Served and Its Competitors
Table 83. Schrцdinger AI Pharma Product Offered
Table 84. Schrцdinger Main Business
Table 85. Schrцdinger AI Pharma Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Schrцdinger Latest Developments
Table 87. Lantern Pharma Details, Company Type, AI Pharma Area Served and Its Competitors
Table 88. Lantern Pharma AI Pharma Product Offered
Table 89. Lantern Pharma Main Business
Table 90. Lantern Pharma AI Pharma Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Lantern Pharma Latest Developments
Table 92. XtalPi Details, Company Type, AI Pharma Area Served and Its Competitors
Table 93. XtalPi AI Pharma Product Offered
Table 94. XtalPi Main Business
Table 95. XtalPi AI Pharma Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. XtalPi Latest Developments
Table 97. Landos Biopharma Details, Company Type, AI Pharma Area Served and Its Competitors
Table 98. Landos Biopharma AI Pharma Product Offered
Table 99. Landos Biopharma Main Business
Table 100. Landos Biopharma AI Pharma Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. Landos Biopharma Latest Developments
Table 102. Relay Therapeutics Details, Company Type, AI Pharma Area Served and Its Competitors
Table 103. Relay Therapeutics AI Pharma Product Offered
Table 104. Relay Therapeutics AI Pharma Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. Relay Therapeutics Main Business
Table 106. Relay Therapeutics Latest Developments
Table 107. Accutar Biotech Details, Company Type, AI Pharma Area Served and Its Competitors
Table 108. Accutar Biotech AI Pharma Product Offered
Table 109. Accutar Biotech Main Business
Table 110. Accutar Biotech AI Pharma Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 111. Accutar Biotech Latest Developments
Table 112. Deep Genomics Details, Company Type, AI Pharma Area Served and Its Competitors
Table 113. Deep Genomics AI Pharma Product Offered
Table 114. Deep Genomics Main Business
Table 115. Deep Genomics AI Pharma Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 116. Deep Genomics Latest Developments
Table 117. Oncocross Details, Company Type, AI Pharma Area Served and Its Competitors
Table 118. Oncocross AI Pharma Product Offered
Table 119. Oncocross Main Business
Table 120. Oncocross AI Pharma Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 121. Oncocross Latest Developments
Table 122. AI Therapeutics Details, Company Type, AI Pharma Area Served and Its Competitors
Table 123. AI Therapeutics AI Pharma Product Offered
Table 124. AI Therapeutics Main Business
Table 125. AI Therapeutics AI Pharma Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 126. AI Therapeutics Latest Developments
Table 127. BioMap Details, Company Type, AI Pharma Area Served and Its Competitors
Table 128. BioMap AI Pharma Product Offered
Table 129. BioMap Main Business
Table 130. BioMap AI Pharma Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 131. BioMap Latest Developments
Table 132. METiS Pharmaceuticals Details, Company Type, AI Pharma Area Served and Its Competitors
Table 133. METiS Pharmaceuticals AI Pharma Product Offered
Table 134. METiS Pharmaceuticals Main Business
Table 135. METiS Pharmaceuticals AI Pharma Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 136. METiS Pharmaceuticals Latest Developments
Table 137. NeoX Biotech Details, Company Type, AI Pharma Area Served and Its Competitors
Table 138. NeoX Biotech AI Pharma Product Offered
Table 139. NeoX Biotech Main Business
Table 140. NeoX Biotech AI Pharma Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 141. NeoX Biotech Latest Developments
Table 142. StoneWise Details, Company Type, AI Pharma Area Served and Its Competitors
Table 143. StoneWise AI Pharma Product Offered
Table 144. StoneWise Main Business
Table 145. StoneWise AI Pharma Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 146. StoneWise Latest Developments
Table 147. Deep Intelligent Pharma Details, Company Type, AI Pharma Area Served and Its Competitors
Table 148. Deep Intelligent Pharma AI Pharma Product Offered
Table 149. Deep Intelligent Pharma Main Business
Table 150. Deep Intelligent Pharma AI Pharma Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 151. Deep Intelligent Pharma Latest Developments
Table 152. Gigaceuticals Details, Company Type, AI Pharma Area Served and Its Competitors
Table 153. Gigaceuticals AI Pharma Product Offered
Table 154. Gigaceuticals AI Pharma Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 155. Gigaceuticals Main Business
Table 156. Gigaceuticals Latest Developments
Table 157. Chemical.AI Details, Company Type, AI Pharma Area Served and Its Competitors
Table 158. Chemical.AI AI Pharma Product Offered
Table 159. Chemical.AI Main Business
Table 160. Chemical.AI AI Pharma Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 161. Chemical.AI Latest Developments
Table 162. Artivila Details, Company Type, AI Pharma Area Served and Its Competitors
Table 163. Artivila AI Pharma Product Offered
Table 164. Artivila Main Business
Table 165. Artivila AI Pharma Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 166. Artivila Latest Developments
Table 167. Galixir Details, Company Type, AI Pharma Area Served and Its Competitors
Table 168. Galixir AI Pharma Product Offered
Table 169. Galixir Main Business
Table 170. Galixir AI Pharma Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 171. Galixir Latest Developments
Table 172. Xbiome Details, Company Type, AI Pharma Area Served and Its Competitors
Table 173. Xbiome AI Pharma Product Offered
Table 174. Xbiome Main Business
Table 175. Xbiome AI Pharma Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 176. Xbiome Latest Developments
LIST OF FIGURES
Figure 1. AI Pharma Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global AI Pharma Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. AI Pharma Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. AI Pharma Sales Market Share by Country/Region (2023)
Figure 8. AI Pharma Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global AI Pharma Market Size Market Share by Type in 2023
Figure 10. AI Pharma in Preclinical Stage (Optimization of Lead Compounds, etc.)
Figure 11. Global AI Pharma Market: Preclinical Stage (Optimization of Lead Compounds, etc.) (2019-2024) & ($ Millions)
Figure 12. AI Pharma in Clinical Trial Phase (Predicting Treatment Outcome, etc.)
Figure 13. Global AI Pharma Market: Clinical Trial Phase (Predicting Treatment Outcome, etc.) (2019-2024) & ($ Millions)
Figure 14. Global AI Pharma Market Size Market Share by Application in 2023
Figure 15. Global AI Pharma Revenue Market Share by Player in 2023
Figure 16. Global AI Pharma Market Size Market Share by Regions (2019-2024)
Figure 17. Americas AI Pharma Market Size 2019-2024 ($ Millions)
Figure 18. APAC AI Pharma Market Size 2019-2024 ($ Millions)
Figure 19. Europe AI Pharma Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa AI Pharma Market Size 2019-2024 ($ Millions)
Figure 21. Americas AI Pharma Value Market Share by Country in 2023
Figure 22. United States AI Pharma Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada AI Pharma Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico AI Pharma Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil AI Pharma Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC AI Pharma Market Size Market Share by Region in 2023
Figure 27. APAC AI Pharma Market Size Market Share by Type in 2023
Figure 28. APAC AI Pharma Market Size Market Share by Application in 2023
Figure 29. China AI Pharma Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan AI Pharma Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea AI Pharma Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia AI Pharma Market Size Growth 2019-2024 ($ Millions)
Figure 33. India AI Pharma Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia AI Pharma Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe AI Pharma Market Size Market Share by Country in 2023
Figure 36. Europe AI Pharma Market Size Market Share by Type (2019-2024)
Figure 37. Europe AI Pharma Market Size Market Share by Application (2019-2024)
Figure 38. Germany AI Pharma Market Size Growth 2019-2024 ($ Millions)
Figure 39. France AI Pharma Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK AI Pharma Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy AI Pharma Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia AI Pharma Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa AI Pharma Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa AI Pharma Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa AI Pharma Market Size Market Share by Application (2019-2024)
Figure 46. Egypt AI Pharma Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa AI Pharma Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel AI Pharma Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey AI Pharma Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country AI Pharma Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas AI Pharma Market Size 2025-2030 ($ Millions)
Figure 52. APAC AI Pharma Market Size 2025-2030 ($ Millions)
Figure 53. Europe AI Pharma Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa AI Pharma Market Size 2025-2030 ($ Millions)
Figure 55. United States AI Pharma Market Size 2025-2030 ($ Millions)
Figure 56. Canada AI Pharma Market Size 2025-2030 ($ Millions)
Figure 57. Mexico AI Pharma Market Size 2025-2030 ($ Millions)
Figure 58. Brazil AI Pharma Market Size 2025-2030 ($ Millions)
Figure 59. China AI Pharma Market Size 2025-2030 ($ Millions)
Figure 60. Japan AI Pharma Market Size 2025-2030 ($ Millions)
Figure 61. Korea AI Pharma Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia AI Pharma Market Size 2025-2030 ($ Millions)
Figure 63. India AI Pharma Market Size 2025-2030 ($ Millions)
Figure 64. Australia AI Pharma Market Size 2025-2030 ($ Millions)
Figure 65. Germany AI Pharma Market Size 2025-2030 ($ Millions)
Figure 66. France AI Pharma Market Size 2025-2030 ($ Millions)
Figure 67. UK AI Pharma Market Size 2025-2030 ($ Millions)
Figure 68. Italy AI Pharma Market Size 2025-2030 ($ Millions)
Figure 69. Russia AI Pharma Market Size 2025-2030 ($ Millions)
Figure 70. Spain AI Pharma Market Size 2025-2030 ($ Millions)
Figure 71. Egypt AI Pharma Market Size 2025-2030 ($ Millions)
Figure 72. South Africa AI Pharma Market Size 2025-2030 ($ Millions)
Figure 73. Israel AI Pharma Market Size 2025-2030 ($ Millions)
Figure 74. Turkey AI Pharma Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries AI Pharma Market Size 2025-2030 ($ Millions)
Figure 76. Global AI Pharma Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global AI Pharma Market Size Market Share Forecast by Application (2025-2030)
Figure 1. AI Pharma Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global AI Pharma Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. AI Pharma Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. AI Pharma Sales Market Share by Country/Region (2023)
Figure 8. AI Pharma Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global AI Pharma Market Size Market Share by Type in 2023
Figure 10. AI Pharma in Preclinical Stage (Optimization of Lead Compounds, etc.)
Figure 11. Global AI Pharma Market: Preclinical Stage (Optimization of Lead Compounds, etc.) (2019-2024) & ($ Millions)
Figure 12. AI Pharma in Clinical Trial Phase (Predicting Treatment Outcome, etc.)
Figure 13. Global AI Pharma Market: Clinical Trial Phase (Predicting Treatment Outcome, etc.) (2019-2024) & ($ Millions)
Figure 14. Global AI Pharma Market Size Market Share by Application in 2023
Figure 15. Global AI Pharma Revenue Market Share by Player in 2023
Figure 16. Global AI Pharma Market Size Market Share by Regions (2019-2024)
Figure 17. Americas AI Pharma Market Size 2019-2024 ($ Millions)
Figure 18. APAC AI Pharma Market Size 2019-2024 ($ Millions)
Figure 19. Europe AI Pharma Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa AI Pharma Market Size 2019-2024 ($ Millions)
Figure 21. Americas AI Pharma Value Market Share by Country in 2023
Figure 22. United States AI Pharma Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada AI Pharma Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico AI Pharma Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil AI Pharma Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC AI Pharma Market Size Market Share by Region in 2023
Figure 27. APAC AI Pharma Market Size Market Share by Type in 2023
Figure 28. APAC AI Pharma Market Size Market Share by Application in 2023
Figure 29. China AI Pharma Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan AI Pharma Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea AI Pharma Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia AI Pharma Market Size Growth 2019-2024 ($ Millions)
Figure 33. India AI Pharma Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia AI Pharma Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe AI Pharma Market Size Market Share by Country in 2023
Figure 36. Europe AI Pharma Market Size Market Share by Type (2019-2024)
Figure 37. Europe AI Pharma Market Size Market Share by Application (2019-2024)
Figure 38. Germany AI Pharma Market Size Growth 2019-2024 ($ Millions)
Figure 39. France AI Pharma Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK AI Pharma Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy AI Pharma Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia AI Pharma Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa AI Pharma Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa AI Pharma Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa AI Pharma Market Size Market Share by Application (2019-2024)
Figure 46. Egypt AI Pharma Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa AI Pharma Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel AI Pharma Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey AI Pharma Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country AI Pharma Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas AI Pharma Market Size 2025-2030 ($ Millions)
Figure 52. APAC AI Pharma Market Size 2025-2030 ($ Millions)
Figure 53. Europe AI Pharma Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa AI Pharma Market Size 2025-2030 ($ Millions)
Figure 55. United States AI Pharma Market Size 2025-2030 ($ Millions)
Figure 56. Canada AI Pharma Market Size 2025-2030 ($ Millions)
Figure 57. Mexico AI Pharma Market Size 2025-2030 ($ Millions)
Figure 58. Brazil AI Pharma Market Size 2025-2030 ($ Millions)
Figure 59. China AI Pharma Market Size 2025-2030 ($ Millions)
Figure 60. Japan AI Pharma Market Size 2025-2030 ($ Millions)
Figure 61. Korea AI Pharma Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia AI Pharma Market Size 2025-2030 ($ Millions)
Figure 63. India AI Pharma Market Size 2025-2030 ($ Millions)
Figure 64. Australia AI Pharma Market Size 2025-2030 ($ Millions)
Figure 65. Germany AI Pharma Market Size 2025-2030 ($ Millions)
Figure 66. France AI Pharma Market Size 2025-2030 ($ Millions)
Figure 67. UK AI Pharma Market Size 2025-2030 ($ Millions)
Figure 68. Italy AI Pharma Market Size 2025-2030 ($ Millions)
Figure 69. Russia AI Pharma Market Size 2025-2030 ($ Millions)
Figure 70. Spain AI Pharma Market Size 2025-2030 ($ Millions)
Figure 71. Egypt AI Pharma Market Size 2025-2030 ($ Millions)
Figure 72. South Africa AI Pharma Market Size 2025-2030 ($ Millions)
Figure 73. Israel AI Pharma Market Size 2025-2030 ($ Millions)
Figure 74. Turkey AI Pharma Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries AI Pharma Market Size 2025-2030 ($ Millions)
Figure 76. Global AI Pharma Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global AI Pharma Market Size Market Share Forecast by Application (2025-2030)
More Publications
Global MEMS Differential Pressure Sensor Market Growth 2023-2029
US$ 3,660.00
February 2023
101 pages
Global Internet of Things (IoT) Developers Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
December 2024
124 pages
Global LEC Grown GaAs Market Growth 2025-2031
US$ 3,660.00
October 2026
78 pages
Global Allied Healthcare Staffing Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
March 2023
123 pages
